| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.8B | $0.8B | $0.7B | $0.6B | $0.5B | $0.5B | $0.5B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.0B | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.69 | $1.35 | $1.37 | $0.81 | $0.50 | $0.38 | $0.53 | $0.24 |
| EPS (Diluted) | $1.69 | $1.35 | $1.36 | $0.81 | $0.50 | $0.38 | $0.53 | $0.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.2B | $7.5B | $7.5B | $6.7B | $6.7B | $6.1B | $6.2B | $5.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.2B | $0.4B | $0.4B | $0.3B | $0.4B | $0.1B | $0.1B |
| Total Liabilities | $6.3B | $6.7B | $6.9B | $6.1B | $5.8B | $5.2B | $5.3B | $5.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.9B | $0.8B | $0.7B | $0.6B | $0.9B | $0.8B | $0.8B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.3B | $0.3B | $0.6B | $0.5B | $0.2B | $0.1B |
| Investing Cash Flow | $0.0B | $-0.2B | $-0.9B | $-0.3B | $-1.1B | $-0.2B | $-0.3B | $-0.4B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.5B | $-0.4B | $0.6B | $0.1B | $0.4B | $0.0B | $0.2B | $-0.9B |